These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32707054)

  • 1. Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67.
    Milman T; Zhang Q; Ang S; Elder D; Ida CM; Salomao DR; Lally SE; Shields JA; Hamershock RA; Sioufi K; Shields CL; Eagle RC
    Hum Pathol; 2020 Sep; 103():107-119. PubMed ID: 32707054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Profiling of Conjunctival Melanocytic Intraepithelial Lesions, Including SOX10, HMB45, Ki67, and P16.
    Milman T; Zhang Q; Ang S; Elder D; Lally SE; Shields JA; Hamershock RA; Sioufi K; Shields CL; Eagle RC
    Am J Ophthalmol; 2021 Feb; 222():148-156. PubMed ID: 33002486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p16-Ki-67-HMB45 Immunohistochemistry Scoring System is Highly Concordant With the Fluorescent In Situ Hybridization Test to Differentiate Between Melanocytic Nevi and Melanomas.
    Uguen A; Uguen M; Guibourg B; Talagas M; Marcorelles P; De Braekeleer M
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):361-367. PubMed ID: 27490764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRAME and Historical Immunohistochemical Antibodies Ki-67, P16, and HMB-45 in Ambiguous Melanocytic Tumors.
    Mert M; Bozdogan O; Bozdogan N; Gamsızkan M; Safali M
    Am J Dermatopathol; 2024 Oct; 46(10):653-662. PubMed ID: 38916203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
    Garola R; Singh V
    Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining.
    Soon AK; Brownstein S; Tang T; Saleh S; Jiang K; Levac J; Blanco P; Farmer J
    Can J Ophthalmol; 2019 Dec; 54(6):699-707. PubMed ID: 31836103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16ink4a expression in benign and malignant melanocytic conjunctival lesions.
    Zoroquiain P; Fernandes BF; González S; Novais GN; Schalper KA; Burnier MN
    Int J Surg Pathol; 2012 Jun; 20(3):240-5. PubMed ID: 22287653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
    Bahmad HF; Oh KS; Alexis J
    J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of p16 immunohistochemical stain to help differentiate inflamed melanocytic nevi from metastatic melanoma in the setting of immunotherapy.
    Adelman M; Lyons AB; Seale L; Friedman BJ
    J Am Acad Dermatol; 2020 Apr; 82(4):e117-e119. PubMed ID: 31765681
    [No Abstract]   [Full Text] [Related]  

  • 11. A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma.
    Uguen A; Talagas M; Costa S; Duigou S; Bouvier S; De Braekeleer M; Marcorelles P
    Diagn Pathol; 2015 Oct; 10():195. PubMed ID: 26503349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
    LeBlanc RE; Miller DM; Zegans ME
    J Cutan Pathol; 2021 Dec; 48(12):1442-1448. PubMed ID: 34089198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
    Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
    Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
    Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
    Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
    Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
    Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and immunohistopathological study of conjunctival melanocytic lesions in pediatric and adolescent patients. A case series.
    Bogdănici CM; Costea CF; Dumitrescu GF; Sava A; Ciobanu Apostol DG; Scripcariu DV; Nicoară SD; Tănase DM; Andriescu EC; Cărăuleanu A; Danciu M; Sălăvăstru SC; Schmitzer S; Cucu AI; Niagu IA
    Rom J Morphol Embryol; 2021; 62(4):907-915. PubMed ID: 35673810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of sex hormone receptors and cell cycle proteins in melanocytic lesions of the ocular conjunctiva.
    Pache M; Glatz-Krieger K; Sauter G; Meyer P
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):113-7. PubMed ID: 16003514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesions.
    Reddy HS; Keene CD; Chang SH; Jian-Amadi A; Cimino PJ
    Exp Mol Pathol; 2017 Apr; 102(2):198-202. PubMed ID: 28161440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
    Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
    J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.